M&A: Page 11
-
Courtesy of Abiomed
J&J to buy heart device maker Abiomed for $16.6B in year’s largest medtech deal
J&J will gain Abiomed’s heart pump devices amid a booming cardiac care market.
By Elise Reuter • Updated Nov. 2, 2022 -
Courtesy of Thermo Fisher Scientific
Thermo Fisher will buy The Binding Site for $2.6B to gain specialty diagnostics portfolio
The U.K.-based firm makes two blood tests for multiple myeloma.
By Elise Reuter • Oct. 31, 2022 -
Spencer Platt/Getty via Getty Images
Medtech M&A decline poised to continue in 2023 amid ‘bumpy’ market: report
Dealmaking has dropped as companies grapple with surging inflation and decreased spending by hospitals, according to EY.
By Elise Reuter • Oct. 26, 2022 -
Courtesy of AlertWatch
BioIntelliSense buys AlertWatch, expanding Medtronic patient monitoring partnership
Medtronic will distribute AlertWatch to hospitals in the U.S. alongside BioIntelliSense’s wearable device for continuous remote monitoring.
By Nick Paul Taylor • Oct. 25, 2022 -
Courtesy of Medtronic
Medtronic’s planned spinoff ‘doesn’t move the needle’ in growth strategy: analysts
Combining patient monitoring and respiratory intervention businesses into a separate company may not be enough to address investor concerns.
By Elise Reuter • Oct. 24, 2022 -
Courtesy of MedAlliance
Cordis to spend $235M to buy Swiss maker of alternative to paclitaxel balloons
As regulatory and sales milestones are hit, Cordis could pay up to $900 million in total.
By Nick Paul Taylor • Oct. 19, 2022 -
Courtesy of Qiagen
Bio-Rad, Qiagen are in talks over $10B merger, WSJ reports
While the two companies have been in talks for some time, the deal may fall through, the report said, citing people familiar with the matter.
By Ricky Zipp • Updated Oct. 11, 2022 -
Courtesy of Standard Bariatrics
Teleflex completes acquisition of Standard Bariatrics amid slow year for medtech M&A
The $170 million transaction reflects the selective nature of industry activity.
By Peter Green , Elise Reuter • Sept. 29, 2022 -
Permission granted by Clik-FIX
B. Braun acquires suite of catheter securement products from Starboard medical for undisclosed amount
The six acquired devices would improve patient care and extend B. Braun’s position in IV therapy, the company says.
By Elise Reuter • Sept. 28, 2022 -
Retrieved from Catheter Precision website on September 13, 2022
Catheter Precision agrees to reverse merger, securing cash to target cardiac electrophysiology market
By merging into Ra Medical Systems, Catheter Precision has access to public markets and a pool of cash needed to bring its product to market.
By Nick Paul Taylor • Sept. 13, 2022 -
Courtesy of Illumina
Illumina’s hold on Grail depends now on separate appeals in US, Europe
Even as it plans to appeal a European Commission decision and the FTC plans to appeal a U.S. ruling, Illumina say it’s preparing for ‘strategic alternatives’ to its acquisition of early cancer detection firm Grail.
By Elise Reuter • Updated Sept. 7, 2022 -
Retrieved from Olympus on August 30, 2022
Olympus to sell microscope unit for $3.1B as it bolsters focus on medical technology
Bain Capital has taken the other side of the deal, paying $3.1 billion for a business it said is “at the frontier of digital optical technology in life sciences and industrial end markets.”
By Nick Paul Taylor • Aug. 30, 2022 -
Retrieved from NJ Medical School Website on August 25, 2022
Labcorp adds to hospital lab buying streak with New Jersey acquisition
The purchase comes as hospitals work to trim costs and testing firms seek stable revenue streams as COVID-19 testing winds down.
By Peter Green , Rebecca Pifer • Aug. 25, 2022 -
Courtesy of Standard Bariatrics
Teleflex will buy Standard Bariatrics for $170M to gain Titan stapler
Standard’s investors could receive an additional $130 million if the unit reaches certain commercial milestones under Teleflex’s ownership.
By Elise Reuter • Aug. 22, 2022 -
Permission granted by Akili Interactive
Akili raises $163M in ‘blank-check’ merger, plans to commercialize digital treatment for ADHD
Akili’s share price fell as much as 55 percent on the Nasdaq by mid-morning Monday, its first day of trading after merging with a special purpose acquisition company.
By Elise Reuter • Aug. 22, 2022 -
Boston Scientific acquires biomaterials firm Obsidio to bolster embolization business
Obsidio’s Gel Emobolic Material technology was cleared by the FDA in July.
By Ricky Zipp • Aug. 15, 2022 -
Courtesy of https://www.mementor.de/
ResMed buys Mementor for prescription digital health app, continuing German expansion
ResMed will integrate the startup into its German operation as a separate business segment and use it as a platform for further digital health development.
By Nick Paul Taylor • Aug. 4, 2022 -
Illumina vows to fight EU efforts to block $8B Grail merger
Illumina acquired the liquid biopsy company in 2021, despite pending anti-competitiveness investigations on both sides of the Atlantic.
By Elise Reuter • Updated Aug. 2, 2022 -
Alex Wong via Getty Images
BD buys MedKeeper for $93M to continue expansion into pharmacy technology
The company sees MedKeeper’s software as a solution for pharmacies facing COVID-related labor shortages.
By Nick Paul Taylor • July 29, 2022 -
Don MacKinnon via Getty Images
3M to spin out its healthcare business
The decision comes amid spin-offs by several large medtech firms, including J&J and GE.
By Elise Reuter • July 26, 2022 -
seb_ra via Getty Images
AbbVie agrees to pay $60M for rights to acquire implantable glaucoma device
The biotech company said the deal is an opportunity to grow its eye-care business.
By Elise Reuter • July 20, 2022 -
Illumina fails to block EU antitrust review of $8B Grail merger
By siding with the European Commission, the General Court has cleared the EU to resume a review that could lead to it blocking the deal and fining Illumina.
By Nick Paul Taylor • July 18, 2022 -
Permission granted by CathWorks
Medtronic lands option to buy artery disease player CathWorks for up to $585M
CathWorks has the right to compel Medtronic to complete the acquisition if it chooses not to exercise its option.
By Nick Paul Taylor • July 13, 2022 -
Chip Somodevilla via Getty Images
Ex-Mazor executive charged by SEC with insider trading over Medtronic's $1.6B buyout
Doron Tavlin, who was Mazor’s vice president of business development, is accused by the agency of profiting from his inside knowledge of the pending takeover.
By Nick Paul Taylor • July 11, 2022 -
Maks_Lab via Getty Images
Medtech M&A falls 85% but activity could rebound in second half: report
PwC highlights a range of barriers that could stop acquisitions, including supply chain issues, scrutiny from the Federal Trade Commission and geopolitical concerns.
By Nick Paul Taylor • June 24, 2022
Previous
